The present study showed that the administration of the sulfated polysaccharide fucoidan improves the symptoms of psoriasis, an immune disorder disease, changes the composition of intestinal microbiota to include high relative abundance of Bacteroidetes, and improves the gut environment by increasing the volumes of mucin and IgA. Here, CD79A is linked to psoriasis.